liminatuspharma.com (LIMN) - Volume dana dhuwit perusahaan

Simbol resmi perusahaan Liminatus Pharma (LIMN)

Liminatus Pharma's efficiency is evidenced by the implementation of energy-saving technologies and emission filtration within its laboratories. Current cash reserves clearly demonstrate liquidity, where the 0.00 metric determines this level. Fundamentals are bolstered by the global diversification of biomaterials to protect margins and growing interest from the scientific community in innovative developments regarding solid tumor therapy.

LIMN - Cadangan dhuwit perusahaan Liminatus Pharma Corp ing rentang 02.05.2025 - 21.11.2026

Rincian analitis perusahaan Liminatus Pharma

Pambiji fundamental perusahaan:Liminatus Pharma Inc. LIMN
Produk merek Liminatus Pharma LLC

Liminatus Pharma's intensive preparation for clinical trials of CAR-T therapy and CD47 inhibitors correlates directly with its cash position, which reflects the volume of highly liquid reserves. This metric measures the actual cash balance, allowing investors to assess the burn rate and the risk of a liquidity gap, which determines the company's market value through the lens of the financial sustainability of its innovative pipeline.

Pesaing Liminatus Pharma (LIMN)

Dhuwit awis perusahaan IBRX (ImmunityBio Corp)|Gunggung dana dhuwit perusahaan IMCR|Volume dana dhuwit perusahaan JANX (Janux Therapeutics, Inc.)|Sisa dhuwit perusahaan RCUS|zymeworks.com - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Tango Therapeutics Corp|Iovance Biotherapeutics (IOVA) - Dana dhuwit perusahaan|Immatics N.V. - Sisa dhuwit perusahaan|XNCR (xencor.com) - Volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan Compass Therapeutics Inc|Dana dhuwit perusahaan Replimune (REPL)|LYEL: Total volume dana dhuwit perusahaan|Innate Pharma SA - Dhuwit awis perusahaan|Pyxis Oncology, Inc. (PYXS) - Cadangan dhuwit perusahaan|Compugen - Volume dana dhuwit perusahaan|Aset likuid perusahaan IO Biotech Inc IOBT|STRO (Sutro Biopharma Inc.) - Dhuwit awis perusahaan|INKT - Aset likuid perusahaan|Dana dhuwit perusahaan werewolftx.com|Dhuwit awis perusahaan Immix Biopharma, Inc. (IMMX)|Dhuwit awis perusahaan ALXO (ALX Oncology Holdings)|Dana dhuwit perusahaan CUE (Cue Biopharma)|Volume dana dhuwit perusahaan PDSB (PDS Biotechnology Corp)|sonnetbio.com (SONN) - Cadangan dhuwit perusahaan|MAIA Biotechnology - Volume dana dhuwit perusahaan|lavatherapeutics.com - Gunggung dana dhuwit perusahaan|NextCure (NXTC) - Dana dhuwit perusahaan|Leap Therapeutics Inc - Sisa dhuwit perusahaan|Dhuwit awis perusahaan INTS|Dana dhuwit perusahaan SNSE|Volume dana dhuwit perusahaan TOVX|GRTS - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan kinetabio.com KA|Sisa dhuwit perusahaan NEXI|turnstonebio.com - Volume dana dhuwit perusahaan|VCNX (Vaccinex, Inc) - Dhuwit awis lan setara dhuwit awis perusahaan|Harpoon Therapeutics (HARP) - Dana dhuwit perusahaan